These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10320048)

  • 41. The role of insulin receptors and receptor antibodies in states of altered insulin action.
    Kahn CR
    Proc Soc Exp Biol Med; 1979 Oct; 162(1):13-21. PubMed ID: 504220
    [No Abstract]   [Full Text] [Related]  

  • 42. Insulin mediators: structure and formation.
    Larner J; Huang LC; Tang G; Suzuki S; Schwartz CF; Romero G; Roulidis Z; Zeller K; Shen TY; Oswald AS
    Cold Spring Harb Symp Quant Biol; 1988; 53 Pt 2():965-71. PubMed ID: 3076102
    [No Abstract]   [Full Text] [Related]  

  • 43. The insulin signaling pathway.
    Taha C; Klip A
    J Membr Biol; 1999 May; 169(1):1-12. PubMed ID: 10227847
    [No Abstract]   [Full Text] [Related]  

  • 44. Insulin mediators and the mechanism of insulin action.
    Romero G; Larner J
    Adv Pharmacol; 1993; 24():21-50. PubMed ID: 8504064
    [No Abstract]   [Full Text] [Related]  

  • 45. [Dysfunction of insulin information transduction at the onset of diabetes mellitus].
    kasuga M
    Nihon Naika Gakkai Zasshi; 2007 Feb; 96 Suppl():51-5. PubMed ID: 17373314
    [No Abstract]   [Full Text] [Related]  

  • 46. Insulin action 1991.
    Taylor R
    Clin Endocrinol (Oxf); 1991 Feb; 34(2):159-71. PubMed ID: 2022067
    [No Abstract]   [Full Text] [Related]  

  • 47. [Model of signal transduction through insulin receptors].
    Kasuga M
    Nihon Naibunpi Gakkai Zasshi; 1987 Dec; 63 Suppl():1503-14. PubMed ID: 3327711
    [No Abstract]   [Full Text] [Related]  

  • 48. Insulin in the brain.
    Baskin DG; Figlewicz DP; Woods SC; Porte D; Dorsa DM
    Annu Rev Physiol; 1987; 49():335-47. PubMed ID: 3551804
    [No Abstract]   [Full Text] [Related]  

  • 49. Potential role of phospholipid-signaling systems in insulin action and states of clinical insulin resistance.
    Farese RV; Cooper DR
    Diabetes Metab Rev; 1989 Aug; 5(5):455-74. PubMed ID: 2667929
    [No Abstract]   [Full Text] [Related]  

  • 50. [Insulin].
    Saito Y; Tarui S
    Horumon To Rinsho; 1975; Suppl():125-36. PubMed ID: 1242025
    [No Abstract]   [Full Text] [Related]  

  • 51. Insulin: signal transmission and short-term effects on the cytoskeleton and protein synthesis.
    Almås B; Pryme IF; Vedeler A; Hesketh JE
    Int J Biochem; 1992 Feb; 24(2):183-91. PubMed ID: 1733785
    [No Abstract]   [Full Text] [Related]  

  • 52. The insulin system: influence of antioxidants.
    Preuss HG
    J Am Coll Nutr; 1998 Apr; 17(2):101-2. PubMed ID: 9550450
    [No Abstract]   [Full Text] [Related]  

  • 53. On the function of insulin: a general theory.
    JACOBS HR
    Q Bull Northwest Univ Med Sch; 1947; 21(4):329-34. PubMed ID: 20271390
    [No Abstract]   [Full Text] [Related]  

  • 54. THEMIS-tery is solved.
    Wiest DL
    Nat Immunol; 2017 Mar; 18(4):368-370. PubMed ID: 28323266
    [No Abstract]   [Full Text] [Related]  

  • 55. Methanolic leaf extract of Gymnema sylvestre augments glucose uptake and ameliorates insulin resistance by upregulating glucose transporter-4, peroxisome proliferator-activated receptor-gamma, adiponectin, and leptin levels in vitro.
    Kumar PM; Venkataranganna MV; Manjunath K; Viswanatha GL; Ashok G
    J Intercult Ethnopharmacol; 2016; 5(2):146-52. PubMed ID: 27104035
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA-29a induces insulin resistance by targeting PPARδ in skeletal muscle cells.
    Zhou Y; Gu P; Shi W; Li J; Hao Q; Cao X; Lu Q; Zeng Y
    Int J Mol Med; 2016 Apr; 37(4):931-8. PubMed ID: 26936652
    [TBL] [Abstract][Full Text] [Related]  

  • 57. How do we continue treatment in patients with type 2 diabetes when therapeutic goals are not reached with oral antidiabetes agents and lifestyle? Incretin versus insulin treatment.
    Gallwitz B; Bretzel RG
    Diabetes Care; 2013 Aug; 36 Suppl 2(Suppl 2):S180-9. PubMed ID: 23882044
    [No Abstract]   [Full Text] [Related]  

  • 58. Inhibitory effect of IL-8 on insulin action in human adipocytes via MAP kinase pathway.
    Kobashi C; Asamizu S; Ishiki M; Iwata M; Usui I; Yamazaki K; Tobe K; Kobayashi M; Urakaze M
    J Inflamm (Lond); 2009 Aug; 6():25. PubMed ID: 19709445
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1.
    Ozes ON; Akca H; Mayo LD; Gustin JA; Maehama T; Dixon JE; Donner DB
    Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4640-5. PubMed ID: 11287630
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A role for protein kinase Bbeta/Akt2 in insulin-stimulated GLUT4 translocation in adipocytes.
    Hill MM; Clark SF; Tucker DF; Birnbaum MJ; James DE; Macaulay SL
    Mol Cell Biol; 1999 Nov; 19(11):7771-81. PubMed ID: 10523666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.